Simpson Curran 4/A
4/A · REGENXBIO Inc. · Filed Jan 14, 2025
Insider Transaction Report
Form 4/AAmended
REGENXBIO Inc.RGNX
Simpson Curran
DirectorChief Executive Officer
Transactions
- Award
Stock Options (Right to buy)
2025-01-02+478,606→ 478,606 totalExercise: $7.86Exp: 2035-01-02→ Common Stock (478,606 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2026 while the optionee provides continuous service to the Issuer.